Kinichi Hotta

Dr. Kinichi Hotta


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
YSYutaka Saito
Yutaka Saito
TUToshio Uraoka
Toshio Uraoka
YYYuichiro Yamaguchi
Yuichiro Yamaguchi
KHKinichi Hotta
Kinichi Hotta
NSNaoto Sakamoto
Naoto Sakamoto
DSDaizo Saito
Daizo Saito

1 July 2005 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
TOTsuneo Oyama
Tsuneo Oyama
ATAkihisa Tomori
Akihisa Tomori
KHKinichi Hotta
Kinichi Hotta
SMSyuko Morita
Syuko Morita
KKKen Kominato
Ken Kominato
YMYoshinori Miyata
Yoshinori Miyata

1 March 2013 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
HIHiroaki Ikematsu
Hiroaki Ikematsu
YYYusuke Yoda
Yusuke Yoda
TMTakahisa Matsuda
Takahisa Matsuda
YYYuichiro Yamaguchi
Yuichiro Yamaguchi
KHKinichi Hotta
Kinichi Hotta
YSYutaka Saito
Yutaka Saito

21 July 2010 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
KHKinichi Hotta
Kinichi Hotta
TOTsuneo Oyama
Tsuneo Oyama
TSTomoaki Shinohara
Tomoaki Shinohara
YMYoshinori Miyata
Yoshinori Miyata
ATAkiko Takahashi
Akiko Takahashi
ATAkihisa Tomori
Akihisa Tomori

13 March 2021 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
YSYutaka Saito
Yutaka Saito
SOShiro Oka
Shiro Oka
TKTakuji Kawamura
Takuji Kawamura
RSRyo Shimoda
Ryo Shimoda
MSMasau Sekiguchi
Masau Sekiguchi
HIHaruhiro Inoue
Haruhiro Inoue

5 August 2013 in Endoscopy
Verified
Journal Article
Closed access
PDF file
YYYusuke Yoda
Yusuke Yoda
HIHiroaki Ikematsu
Hiroaki Ikematsu
TMTakahisa Matsuda
Takahisa Matsuda
YYYuichiro Yamaguchi
Yuichiro Yamaguchi
KHKinichi Hotta
Kinichi Hotta
YSYutaka Saito
Yutaka Saito
Background and study aims: Patients with submucosal invasive colorectal cancer (SM-CRC) treated with endoscopic resection who are at low risk of lymph node metastasis and local recurrence may be followed up with observation alone, while additional surgery is recommended for those with high risk features. However, the long-term outcomes that these strategies offer are still unclear. The objective of our study was to retrospectively evaluate the long-term outcomes of patients with SM-CRC managed with endoscopic resection. Patients and methods: We retrospectively analyzed all patients with SM-CRC treated by endoscopic resection at six institutions between 2000 and 2007. SM-CRCs with (i) negative vertical margin, (ii) well or moderately differentiated adenocarcinoma, (iii) absence of lymphovascular invasion, and (iv) invasion depth < 1000 µm were classified as low risk. Patients with SM-CRCs without these characteristics were classified as high risk. Outcomes were assessed by 5-year recurrence-free survival (RFS) and recurrence rate. Results: During the study period, 428 patients with SM-CRC (low risk, 126; high risk, 302) who underwent endoscopic resection as their first treatment were enrolled (median follow-up 61 months). Among the 120 patients with low risk features treated by endoscopic resection alone, the 5-year RFS and recurrence rates were 98 % and 0.8 %, respectively. Of the 302 patients with high risk features, 196 underwent additional surgery and 106 were managed with endoscopic resection alone. For those who underwent additional surgery, the 5-year RFS and recurrence rates were 97 % and 3.6 %, respectively. Among the 106 patients managed with endoscopic resection alone, RFS and recurrence rates were 89 % (P < 0.05 vs. low risk patients treated by endoscopic resection alone) and 6.6 % (P < 0.05), respectively. Conclusions: Endoscopic resection alone is adequate for the management of patients with SM-CRC and low risk features. However, in those patients with SM-CRC and high risk features, surgery should be considered in addition to endoscopic resection.